Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (4)
2024 (528)
2023 (586)
2022 (724)
2021 (1399)
2020 (842)
All (4083)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Havervall S
JSON
CSV
XLSX
TXT
Family name
Havervall
Given name
Sebastian
Initials
S
ORCID
ORCID
0000-0003-1671-8183
Affiliations
Division of Internal Medicine Department of Clinical Sciences Karolinska Institutet Danderyd Hospital Stockholm Sweden.
9 publications
PubMed
DOI
Crossref
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
Bladh O, Greilert-Norin N,
Havervall S
, ...,
Klingström J
, Thålin C
N Engl J Med
389
(17) 1626-1628 [2023-10-26; online 2023-10-27]
Category: Biochemistry
Category: Genomics & transcriptomics
Category: Health
Funder: KAW/SciLifeLab National COVID program
Type: Journal article
PubMed
DOI
Crossref
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
Havervall S
, Marking U, Svensson J, ..., Smed-Sörensen A, Thålin C
N Engl J Med
387
(14) 1333-1336 [2022-10-06; online 2022-09-14]
Category: Biochemistry
Category: Health
Category: Omicron VoC
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Type: Journal article
PubMed
DOI
Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U,
Havervall S
, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines
10
(3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Type: Journal article
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S
,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS One
17
(1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
DOI
Crossref
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
Havervall S
, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C
Clin Transl Immunol
11
(4) - [2022-01-00; online 2022-04-18]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Type: Journal article
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J Intern Med
291
(1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Research Area: Viral sequence evolution
PubMed
DOI
Crossref
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
Havervall S
, Marking U, Greilert-Norin N, ..., Åberg M,
Thålin C
EBioMedicine
70
(-) 103523 [2021-08-00; online 2021-08-12]
Category: Drug Discovery
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunol
10
(7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.
Ng H
,
Havervall S
,
Rosell A
, ...,
Thålin C
,
Phillipson M
Arterioscler Thromb Vasc Biol
41
(2) 988-994 [2021-02-00; online 2020-12-03]
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.1